Knowledge,Attitude,and Practice Towards Mpox and Associated Factors Among HIV-Infected Individuals—Beijing Municipality,China,2023  

作　　者：Yue Gu Ruiqi Ren Jing Han Wenqing Bai Yuanyuan Zhang Haoliang Liu Zhaohe Li Chao Li Rui Song Lei Zhou 

机构地区：[1]Chinese Center for Disease Control and Prevention,Beijing,China [2]National Center for Infectious Diseases,Beijing Ditan Hospital,Capital Medical University,Beijing,China [3]Beijing Key Laboratory of Emerging Infectious Diseases,Institute of Infectious Diseases,Beijing Ditan Hospital,Capital Medical University,Beijing,China [4]Nanjing Medical University,Nanjing City,Jiangsu Province,China

出　　处：《China CDC weekly》2024年第7期109-117,I0001,I0002,共11页中国疾病预防控制中心周报（英文）

基　　金：Provided by the National Natural Science Foundation of the People’s Republic of China(Grant No.71934002);the Beijing Hospitals Authority(Grant No.XMLX202149).

摘　　要：Summary What is already known about this topic?Approximately 50%of patients with mpox are human immunodeficiency virus(HIV)-infected globally.Studies have shown that individuals with advanced HIV infection tend to have more severe clinical manifestations and higher mortality rates after mpox infection.What is added by this report?

关 键 词：MORTALITY INFECT CLINICAL 

分 类 号：R511[医药卫生—内科学]